The Delayed Bill for a Lower-Paid Profession

For Portugal’s pharmacists, the long-run question is not only whether the community-pharmacy workforce kept growing. It is whether pharmacy remained as attractive relative to the careers that applicants could choose instead. This chapter follows that delayed feedback: the sharp fall in pharmacists’ relative wages, the continued flow of graduates after the shock, and the later changes in who applied and enrolled. The evidence supports a distinction between an immediate supply response, which remained strong, and a slower change in the profession’s appeal.

That distinction matters because education and employment operate on different clocks. A student deciding whether to enter an integrated pharmacy program may not become a pharmacist for several years. A person already enrolled can still graduate into a labor market that now offers lower pay. For a time, the existing pipeline can keep employment growing even as the wage signal becomes less favorable. Only later do applications, enrollment, and the composition of entrants reveal how the occupation is being repriced.

Pharmacy lost ground to its alternatives

A wage decline becomes easier to interpret when it is compared with the alternatives visible to the people choosing an occupation. The Portuguese admissions data show that applicants to integrated master’s programs in pharmacy often also applied to medicine and nursing. Medicine was commonly a higher-ranked option—a “reach” choice—while nursing was commonly ranked just below pharmacy, as a “safety” choice. These patterns do not prove that every pharmacy applicant viewed the three careers in the same way, but they make doctors and registered nurses more meaningful comparators than an arbitrary average of all occupations.

The ranked applications also reveal how a prospective pharmacist evaluates options under constraints. A reach choice and a safety choice are not identical substitutes: one may require a higher admission score or offer a different professional status, while the other may be more accessible but still use related health-care preparation. Pharmacy sits between them in the observed decision set, which makes a change in its expected return potentially important even if medicine remains out of reach for many applicants and nursing remains attractive for reasons beyond pay. The application data do not reveal each student’s priorities, but they identify a concrete comparison set rather than an abstract labor-market average.

The comparison is about relative opportunity, not just absolute pay. In 2008–2009, Portuguese pharmacists earned about 40 log points more than registered nurses and sat approximately halfway between nurses and medical doctors. A log-point comparison is a proportional wage difference expressed in logarithmic form; it is useful for comparing groups over time, but it should not be mistaken for a precise euro premium for every individual. The important point is the position of the profession in the health-care wage ladder before the crisis-era reforms.

That position changed substantially. By 2022, the pharmacist–nurse wage gap in Portugal was nearly eliminated, while the real wages of doctors and nurses were relatively stable over the period used in the comparison. Pharmacists’ real wages fell by about 30 percent. The result was not merely that pharmacy pay failed to keep pace with a general decline across highly educated workers. Relative to two plausible alternatives, pharmacy lost much of the premium that had helped distinguish it from nursing and had placed it between nursing and medicine.

The cross-country comparison makes the Portuguese shift look unusual, although it is not a perfect counterfactual.